Inventor · disambiguated record
Darshan Parikh
Also filed as: PARIKH DARSHAN · PARIKH DARSHAN K
13 granted patents·4 pending applications·88 citations·filing 2005–2024
91Inventor score
Top patents by PatentIndex Score
17 records- 0192US9359364B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2014·Granted Jun 7, 2016·10 cites·28 claims
- 0283US10080801B2Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dioneCELGENE CORP·Filed 2014·Granted Sep 25, 2018·7 cites·35 claims
- 0378US11389454B2Tablet compositionsCELGENE CORP·Filed 2017·Granted Jul 19, 2022·2 cites·4 claims
- 0476US9468605B2Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2014·Granted Oct 18, 2016·1 cites·3 claims
- 0576US2024335450A1Tablet compositionsCELGENE CORP·Filed 2024·Application pending·0 cites
- 0670USD835258SPharmaceutical tabletCELGENE CORP·Filed 2018·Granted Dec 4, 2018·11 cites·1 claims
- 0769USD787042SPharmaceutical tabletCELGENE CORP·Filed 2015·Granted May 16, 2017·14 cites·1 claims
- 0869US2022323447A1Tablet compositionsCELGENE CORP·Filed 2022·Application pending·0 cites
- 0968USD787043SPharmaceutical tabletCELGENE CORP·Filed 2015·Granted May 16, 2017·13 cites·1 claims
- 1067USD858741SPharmaceutical tabletCELGENE CORP·Filed 2018·Granted Sep 3, 2019·9 cites·1 claims
- 1167USD835257SPharmaceutical tabletCELGENE CORP·Filed 2017·Granted Dec 4, 2018·10 cites·1 claims
- 1267USD813372SPharmaceutical tabletCELGENE CORP·Filed 2017·Granted Mar 20, 2018·10 cites·1 claims
- 1365US10052322B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2017·Granted Aug 21, 2018·0 cites·18 claims
- 1463USRE49647EFormulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dioneCELGENE CORP·Filed 2020·Granted Sep 12, 2023·0 cites·41 claims
- 1559US9364475B2Tablet formulation of a phosphatidylinositol 3-kinase inhibitorSANOFI SA·Filed 2015·Granted Jun 14, 2016·1 cites·32 claims
- 1656US2009209548A1Formulation for stimulating hair growthPFIZER·Filed 2009·Application pending·0 cites
- 1747US2007225357A1Formulation for Stimulating Hair GrowthPFIZER·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →